RxDoctor Payments Data

Jessica Atrio, MD

Obstetrics & Gynecology · Bronx, NYNPI 1184882714

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,200 of the $13,836 with a category attached, or 88.2%. Gilead accounts for 61.0% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $8,417, more than ten times the $100 reported in 2022. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,836in general payments, 2019–2025

Across 14 payments — averaging $988.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$8K
  • Viiv Healthcare Company$5K
  • Medicines360$100
$737,924in research payments, 2019–2025

Across 162 payments — averaging $4555.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Organon$316K
  • Evofem Biosciences, Inc.$188K
  • Genbiopro, Inc.$159K
  • Merck$46K
  • Mylan Inc.$27K
  • BD$2K

What the payments were for

  • Consulting fees$12,20088%
  • Travel & lodging$1,44010%
  • Food & beverage$1961%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead11$8,436
Viiv Healthcare Company2$5,300
Medicines3601$100

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,836 in reported general payments places this provider in the 95th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York

Medicare billing

Part B allowed, 2024
$2,592
Medicare patients
12
Services billed
24

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Bronx

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →